Host: |
CHO cells |
Applications: |
ELISA/WB |
Reactivity: |
SARS-CoV-2 |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Cho Cells monoclonal antibody anti-Recombinant-SARS-CoV-2 Spike RBD is suitable for use in ELISA and Western Blot research applications. |
Clonality: |
Monoclonal |
Clone ID: |
36A7 |
Conjugation: |
Unconjugated |
Isotype: |
IgG1 lambda |
Formulation: |
PBS pH 7.4 |
Purification: |
Protein A affinity chromatography following desalting |
Dilution Range: |
Indirect ELISA 0.04 – 0.08 ng/ml |
Storage Instruction: |
The product is stable at 4 °C for several days. Store at-20 °C to-70 °C long term. Avoid multiple freeze-thaw cycles. |
Dissociation Constant: |
6.27 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein) 5.10 x 10-8 M (measured against SARS-CoV-2 Spike S1 protein) |
Specificity: |
SARS-CoV-2 Spike RBDNeutralizing properties: blocks S1 and ACE2 binding in Octet system; IC50 1250 ng/ml measured in live virus neutralization assay |
Immunogen: |
Recombinant SARS-CoV-2 RBD2 protein produced by CHO-based proprietary suspension cell line. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance